Cell proliferation exerts a high demand on protein synthesis, yet the mechanisms coupling 30 the two processes are not fully understood. A kinase and phosphatase screen for 31 activators of translation, based on the formation of stress granules in human cells, 32 revealed cell cycle-associated kinases as major candidates. CDK1 was identified as a 33 positive regulator of global translation, and cell synchronization experiments showed that 34 this is an extra-mitotic function of CDK1. Dephosphorylation of eIF2α and S6K1 signaling 35 were found to act downstream of CDK1. Moreover, Ribo-Seq analysis uncovered that 36 CDK1 exerts a particularly strong effect on the translation of 5'TOP mRNAs, which 37 includes mRNAs encoding for ribosomal proteins and several translation factors. This 38 effect requires the 5'TOP mRNA-binding protein LARP1, concurrent to our finding that 39 LARP1 phosphorylation is strongly dependent on CDK1. Taken together, our results show 40 that CDK1 provides a direct means to couple cell proliferation with biosynthesis of the 41 translation machinery and the rate of protein synthesis. 42
Cell growth, proliferation and progression through the cell cycle strongly depend on the 46 synthesis of new proteins (Pardee, 1989; Polymenis and Aramayo, 2015) . On the one hand, cells exert temporal control over the production of specific proteins during the 48 different phases of the cell cycle (Aviner et al., 2013; Stumpf et al., 2013; Tanenbaum et 49 al., 2015) . On the other hand, cells also need to adjust the overall rate of protein synthesis 50 to the proliferation rate in order to maintain cell size and functionality (Foster et al., 2010) . 51
It is therefore not surprising that modifications of the translation machinery can affect cell 52 proliferation rates, and that deregulation of protein synthesis is increasingly recognized as 53 a major driver of cell transformation (Ruggero and Pandolfi, 2003; Silvera et al., 2010; 54 Truitt and Ruggero, 2016) 55
A few signaling pathways are known to regulate protein synthesis in response to 56 proliferative cues. The mechanistic target of rapamycin complex 1 (mTORC1), e.g., 57
functions as a signaling node that adjusts protein synthesis to cell growth rates and the 58 metabolic status of the cell (Laplante and Sabatini, 2012) . mTORC1 directly 59 phosphorylates 4E-BPs, thereby promoting the translation of a distinct group of mRNAs 60 that strongly depend on the eukaryotic translation initiation factor (eIF) 4E (Gandin et al., 61 2016; Nandagopal and Roux, 2015) . mTORC1 further enhances the translation of mRNAs 62 containing a 5' terminal oligo pyrimidine tract (5'TOP) motif, which includes many mRNAs 63 encoding ribosomal proteins and translation factors (Meyuhas and Kahan, 2015) . 64
The protooncogenes Ras and Myc also control protein synthesis in order to 65 coordinate cellular growth rates with extracellular growth stimuli. While Myc mostly 66 controls translation through transcriptional upregulation of ribosomal components and 67 translation factors (van Riggelen et al., 2010), the Ras/Erk signaling pathway shares some 68 common downstream signals with mTORC1 including phosphorylation of ribosomal 69 protein S6 (RPS6) (Roux and Topisirovic, 2018) . 70
While numerous translation factors are known to be phosphorylated (Roux and 71 Topisirovic, 2018), the regulatory impact of phosphorylation is established only for a few 72 factors such as eIF2α, 4E-BPs and eEF2 (Jackson et al., 2010; Kenney et al., 2014) . 73
Ribosomal proteins are also known to carry various posttranslational modifications (Shi 74 and Barna, 2015) , yet the role of these modifications in controlling protein synthesis is 75 poorly understood. Recently, a systematic approach to identify translationally relevant 76 phosphorylation sites on ribosomal proteins revealed that phosphorylation of RPL12 77 controls the translation of mitosis-specific proteins (Imami et al., 2018) . 78 7 Likewise, we tested non-proliferating RPE1 cells after 48 hours of serum 166 starvation. The cells had entered G0-phase, visible through the appearance of primary 167 cilia (Fig. S2 ), and still responded to CDK1i by a strong reduction of their translation rate 168 ( Fig. 3D ). From these experiments we concluded that enhancing protein synthesis is an 169 extra-mitotic function of CDK1, which likely serves as a means to adjust protein synthesis 170 to the overall proliferation rate rather than to a specific phase of the cell cycle. 171 eIF2α phosphorylation and S6K1 contribute to translation control by CDK1 172
We then sought to explore the signaling pathway by which CDK1 controls protein 173 synthesis. Various types of stress cause suppression of translation initiation via 174 phosphorylation of eIF2α at serine (S)51, which prevents recharging of the initiator eIF2- . Thus, we concluded that eIF2α phosphorylation is 183 alone not responsible for, but contributes to translation inhibition after CDK1i. 184
Next, we examined targets of the mTOR pathway. 4E-BP1, a direct target of 185 mTORC1, showed an increase in phosphorylation upon CDKi, and accumulated in a 186 hypophosphorylated form at 16 and 24 hours of Ro3306 treatment ( Fig. 4A and 4B ). 187
Since 4E-BP1 phosphorylation controls the integrity of the cap-binding complex 188 (Sonenberg and Hinnebusch, 2009 ), we carried out cap pulldown experiments using 7-189 methyl-GTP agarose beads. As expected, inhibition of mTORC1 using Torin1 (Thoreen et 190 al., 2009 ) led to dissociation of eIF4G, eIF4A1 and eIF3B from eIF4E ( Fig. S3C and S3D ). 191 Inhibition of CDK1 by treatment with Ro3306 for 4 or 16 hours, however, did not interfere 192 with integrity of the cap-binding complex ( Fig. S3C and S3D ), indicating that CDKi does 193 not repress translation via inhibition of mTOR signaling. 194 RPS6, a direct target of S6 kinase 1 (S6K1) and indirect target of mTORC1, was 195 found to be strongly dephosphorylated early upon CDK1i ( Fig. 4A and 4B ). We first 196 examined whether S6K1 mediates CDK1-dependent control of translation by generating 197
HeLa cells that stably overexpress wild type (WT) or constitutively active (CA) S6K1. 198 Phosphorylation levels of RPS6 were partially restored in the S6K1 overexpressing cells 199 treated for 4 hours with Ro3306 (Fig. S4A ), and translation suppression upon CDK1i was 200 8 slightly, though significantly, reduced in comparison to control HeLa cells ( Fig. 4D and 201 S4B). We then tested whether RPS6 phosphorylation is responsible for this effect. In 202
MEFs expressing bi-allelic phospho-deficient RPS6 P-/- (Ruvinsky et al., 2005) , Ro3306 203 treatment suppressed translation to the same degree as in control RPS6 P+/+ MEFs (Fig. 204 4E and S4C). Taken together, these results indicated that eIF2α phosphorylation and 205 S6K1 activity contribute to translation control by CDK1, whereas RPS6 phosphorylation is 206 not involved. 207
CDK1 affects phosphorylation of translation-associated factors 208
CDK1 was recently detected in a ribosome interaction capture mass spectrometry 209 analysis (Simsek et al., 2017) , and found to phosphorylate ribosomal protein RPL12 210 (Imami et al., 2018) . Together with our observation that CDK1i affects RPS6 211 phosphorylation ( Fig. 4A and 4B), these findings prompted us to explore whether CDK1 212 might influence more generally the phosphorylation of ribosomal proteins and/or 213 ribosome-associated factors. First, we explored if CDK1 indeed interacts with ribosomes. 214
Polysome profile analysis revealed that a small proportion of CDK1 co-migrates with 215 polysomes, and shifts to lighter fractions upon disassembly of polysomes by RNaseI ( Fig.  216 5A and S5A). 217
We then sought to identify possible targets of CDK1 associated with ribosomes 218 using SILAC-based phosphoproteomics. Ribosomal fractions were obtained through 219 sucrose gradient centrifugation from HeLa cells treated with either DMSO or Ro3306 for 4 220 hours, and subjected to mass spectrometry analysis. Phosphopeptide enrichment using 221 PhosSelect iron affinity gel IMAC beads led to the identification of 2918 phosphorylated 222 residues (Table S3 ). Ro3306-sensitive sites were detected in several ribosomal proteins 223 (RPS6, RPS10, RPS17, RPL12, RPL29), translation factors (eIF2B4, eIF3 subunits, 224 eIF4A1, eIF4B, eIF4GI, eIF5B), translation regulators (LARP1, YTHDF1) as well as 225 mRNA splicing and export factors (SRRM2, SFSWAP, THOC2, ZC3H11A and eIF4A3). A 226 prominent reduction of phosphorylation upon CDKi was observed for RPS6 and LARP1 227 ( Fig. 5B ), and this result could be verified in a second LC-MS/MS analysis using a smaller 228 scale, TiO 2 -based enrichment of phosphopeptides ( Fig. S5B and Table S4 ). 229
CDK1 strongly enhances 5'TOP mRNA translation via LARP1 230
To gain further insight into the translation regulatory function of CDK1, we next performed 231 ribosome footprint (Ribo-Seq) analysis. Cell cycle phase-dependent effects were avoided 232 by using RPE1 cells arrested in G0 through serum starvation, and ribosome density (RD) 233 was measured at an early time point (4 hours) after CDK1i. As an internal standard, equal 234 9 amounts of a yeast lysate were spiked into the RPE1 cell lysates prior to RNaseI 235 digestion, which allowed us to assess both the global and transcript-specific effects of 236 Ro3306 on translation. To reduce distortion of results through ligation biases, the input 237 RNA was fragmented by alkaline hydrolysis and subjected to the same library preparation 238 protocol as the ribosomal footprints. Quality assessment showed the desired read lengths 239 ( Fig. S6A) , pronounced periodicity and ORF enrichment for the footprints, but not the input 240 RNA ( Fig. S6B ), as well as adequate reproducibility between biological replicates ( Fig.  241 S6A-C). As expected, CDK1i led to a global drop in RD ( Fig. 6A , most transcripts below 242 the diagonal), which corresponds to a two-fold reduction in the average RD ( Fig. 6B ). This 243 result is in good agreement with the 3-fold reduction in polysomal ribosomes measured by 244 polysome profiling ( Fig. 3D) . 245
The analysis of individual transcripts revealed that CDK1i causes pronounced 246 suppression of 5'TOP mRNAs, which includes all mRNAs encoding cytosolic ribosomal 247 proteins ( Fig. 6A and 6C ). In contrast, mRNAs encoding mitochondrial ribosomal proteins, 248 which do not contain a 5'TOP motif, or IRES-containing mRNAs, were not particularly 249 sensitive to CDK1i ( Fig. 6A and 6C ). We confirmed in HeLa cells that Ro3306 treatment 250 preferentially reduces the association of 5'TOP mRNAs (RPLP0 and PABPC4) with 251 polysomes, whereas control mRNAs (EIF2α and NCL) were barely affected ( Fig Early experiments measuring the incorporation of radiolabelled nucleosides and amino 273 acids had already pointed to a tight connection between the proliferation rate and the rate 274 of protein synthesis in cultured fibroblast subjected to contact inhibition (Levine et al., 275 1965) or serum deprivation (Rudland, 1974) . Current concepts on mechanisms that 276 couple the two rates focus on the mTOR signaling network, which integrates cues from 277 growth factors and nutritional sensing in order to control a cell growth checkpoint in late 278 G1 (Foster et al., 2010) . The connection is based upon the notion that active mTOR, 279 amongst its many effector functions, promotes cell proliferation as well as protein 280 synthesis and ribosome biogenesis (Laplante and Sabatini, 2012) . 281
Our SG-based screen for potential activators of translation revealed several 282 candidate kinases that are primarily associated with cell cycle, proliferation and DNA 283 damage ( When addressing the mechanism by which CDK1 enhances global protein 317 synthesis, we found that CDK1 influences translation initiation via multiple, possibly 318 redundant pathways. First, we found an increase in eIF2α phosphorylation upon CDKi 319 ( Fig. 4A ), and since translation suppression was reduced in MEFs expressing non-320 phosphorylatable eIF2α S51A (AA) ( Fig. 4C ), one role of CDK1 is to promote recharging 321 of the eIF2-GTP-tRNA i Met ternary complex. Second, we observed a pronounced reduction 322 in RPS6 phosphorylation upon CDKi (Fig. 4A and 5B) , and reduced translation 323 suppression in HeLa cells overexpressing S6K1 (Fig. 4D ) indicated that CDK1 also 324 enhances translation initiation through the S6K1 signaling axis. Of note, CDK1 most likely 325 does not act via mTOR since CDK1i, in contrast to mTOR inhibition, did not alter the 326 integrity of the cap binding complex ( Fig. S3C and S3D ). Third, we could show that CDK1 327 co-sediments with polysomes ( Fig. 5A) , and a recent mass spectrometry approach found 328 CDK1 to be associated with ribosomes (Simsek et al., 2017) . This is in line with the notion 329 that RPL12 is a known substrate of CDK1, and RPL12 phosphorylation was recently 330 shown to enhance a mitotic translation program (Imami et al., 2018 ). Hence, it is possible 331 that CDK1 stimulates global translation by phosphorylating additional proteins of, or 332 associated with, the ribosome. Finally, our results show that CDK1 is a pronounced 333 activator of 5'TOP mRNA translation, which includes the synthesis of all ribosomal 334 proteins (Fig. 6 ). Hence, CDK1 has a sustained effect on global protein synthesis in 335 proliferating cells as it enhances translation at the initiation level, possibly also at the 336 elongation level (Smith and Proud, 2008) , and by promoting biogenesis of the protein 337 synthesis machinery. 338
We were intrigued by the pronounced effect of CDK1i on 5'TOP mRNA translation. 339
In agreement with this finding, it is well known that cell cycle progression tightly correlates 340 with 5'TOP mRNA translation. For example, cell cycle arrest in G0, at the beginning of S-341 phase or in M-phase, strongly reduces translation of 5'TOP mRNAs (Meyuhas and Kahan, 342 2015) . Likewise, translation of 5'TOP mRNAs is low in resting adult liver cells, but high in 343
developing fetal liver cells as well as in proliferating adult liver cells during regeneration 344 12 (Aloni et al., 1992) . We propose that CDK1 has a central role in coupling 5'TOP mRNA 345 translation with the proliferation status of the cell since i) LARP1 phosphorylation is 346 strongly dependent on CDK1 activity ( Fig. 5B) and ii) CDK1 controls 5'TOP mRNA 347 translation in a LARP1-dependent manner (Fig. 6E) . Future studies will need to show if 348 LARP1 is a direct target of CDK1, and address the detailed mechanism by which CDK1 349 antagonizes the inhibitory activity of LARP1 on 5'TOP mRNA translation. 
Generation of stable cell lines and knockout cell lines 412
Hela GFP-G3BP1 cells were generated by plasmid transfection of pCI-puro-GFP-G3BP1 413 (p2163) using PEI. 24 h after transfection, cells were subjected to selection pressure by 414 the addition of 2 µg/ml puromycin (Gibco). After two weeks of selection, mass cell cultures 415 were FACS-sorted using a BD FACSAria IIIu cell sorter. HeLa-FUCCI-Kusabira-Orange-416 hCdt1 and HeLa-FUCCI-mVenus-hGeminin cells were generated by lentiviral transduction 417 of pWPI-FUCCI-Kusabira-Orange-Cdt1-Zeo and pWPI-FUCCI-mVenus-Geminin-Zeo, 418 respectively. Retroviral transduction and generation of stable cell lines was performed as 419 described in (Ruggieri et al., 2012) . In short, 293T cells were seeded into 6 cm-diameter 420 dishes and transfected using the CalPhos mammalian transfection kit (Becton Dickinson) 421 as recommended by the manufacturer. For transfection, the packaging plasmid 422 (pCMVΔ8.91), the transfer vector (pWPI-based) and the VSV envelope glycoprotein 423 expression vector (pMD2.G) were used in a concentration ratio of 3:3:1. Transduction of 424
HeLa cells with the lentiviral particles was repeated three times every 12 h to achieve high 425 number of integrates and thus high expression levels. Transduced cell pools were 426 subjected to selection with medium containing 100 µg/ml zeocin (Invitrogen) and high 427 expressing cells were sorted by FACS. HeLa-HA-S6K1-WT and HeLa-HA-S6K1-CA cells 428 15 were generated similarly by retroviral transduction using pWPI-BLR-HA-S6K1-WT (p3669) 429 and pWPI-BLR-HA-S6K1-CA (F5A-T389E-R5A) (p3671). Cells were subjected to 430 selection pressure by the addition of 5 µg/ml blasticidin (Invitrogen). To create plasmids 431 for expression of LARP1-specific gRNAs, LARP1-oligo1 and LARP1-oligo2 were annealed 432 and cloned into Esp3I-digested LentiCRISPRv2, resulting in a vector designated 433 LentiCRISPR-LARP1gRNA. HEK293T cells were maintained in DMEM medium (Gibco) 434 supplemented with 10% fetal calf serum (Gibco) and 100 units/mL penicillin/streptomycin 435 (Gibco). All cells were cultured at 37°C in 5% (v/v) CO2. One day prior to transfection, 436 HEK293T cells were seeded at a density of 3 x 105 cells/well in 6-well plates. For CDK1 depletion HT2-19 cells were seeded at very low density and cultured in the 460 absence of IPTG for 7 days. RPE1 cells, kindly provided by I. Hoffmann (German Cancer  461 Research Center, Heidelberg), were cultured in HAM's F-12 medium (HAM's F-12 (1:1), 462 Millipore) containing 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml 463 16 streptomycin. HeLa-FUCCI-Kusabira-Orange-hCdt1, HeLa-FUCCI-mVenus-hGeminin and 464
HeLa-GFP-G3BP1 cells were FACS sorted, cultured without selection pressure and 465 maintained at low passage numbers. All cells were cultured at sub-confluency, at 37°C in 466 5% CO 2 . For treatment with inhibitors, cells were seeded the evening before, and Ro-467 3306 (Sigma, 10 µM), Roscovitine (Sigma, 20 µM), Torin-1 (200 nM, Tocris Bioscience) or 468 control solvent (DMSO) were diluted in fresh medium, which was added onto the cells for 469 the indicated times. For synchronization, HeLa cells were subjected to a double thymidine 470 block following standard procedures (18 h 2 mM thymidine, 9 h release, and 18 h 2 mM 471 thymidine). 472
Screening approach and SG score 473 and kd was carried out for 72 h. Cells were fixed for 10 minutes at RT using 4% PFA in 484 PBS supplemented with Hoechst dye (1:10000 diluted). Afterwards, cells were washed 3 485 times and stored in PBS at 4°C and in the dark until examination under the microscope. 486
Seeding, washing and fixation were done with a microplate suspensor (Thermo Scientific 487
Multidrop Combi) in order to ensure fast, synchronous and equal handling. SG formation 488 was analyzed using a Nikon eclipse Ti-E microscope and a Nikon plan Apo 60x oil 489 objective that was constantly supplied with immersion oil by a pumping system. 16 images 490 per well were taken automatically using a sCMOS camera (Flash4, Hamamatsu), Nikon 491 JOBS software and the Nikon perfect focus system, and images were subsequently 492 analyzed by eye. For every phosphotransferase, a SG score was calculated by multiplying 493 the sum of SG-containing cells, observed with all 4 siRNAs, by the number of siRNAs 494 causing SGs. 495
Immunofluorescence (IF) and microscopy 496
Cells were seeded onto glass coverslips one day before drug treatment. Cells were fixed 497 with 4% paraformaldehyde (PFA) for 10 min, permeabilized with 0.5% Triton-X in PBS for 498 10 min and blocked with 3% BSA in PBS for 1 h at RT. Cy3-or Cy2-conjugated secondary 499 donkey antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) were used 500 for detection of primary antibodies. DNA was stained with Hoechst dye (1: 10000, Sigma). 501
Coverslips were mounted onto glass slides using a solution of 14% polyvinol-alcohol 502 (P8136, Sigma) and 30% glycerol in PBS. Microscopy was performed on a Leica DM 503 5000 Microscope using a 20x or 40x dry objective, or a 40x oil objective. Alternatively, a 504
Nikon eclipse Ti-E microscope was used in combination with a 40x dry objective or a 60x 505 oil objective. Images were taken with an Andor CCD camera or a pco edge sCMOS 506 camera, and subsequently processed and analyzed using Adobe Photoshop and Fiji 507 software. 508 Primers 535
Western blot analysis

Polysome profile analysis 558
Cells were seeded one day before the experiment and kept at sub-confluency in order to 559 prevent translation suppression by contact inhibition. Cells were then treated with 100 560 µg/ml cycloheximide (CHX) for 5 min at RT in order to stabilize existing polysomes before 561 washing with ice-cold PBS and harvesting by scraping in polysome lysis buffer (20 mM 562 Tris HCl pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 1 mM DTT, 100 mg/ml CHX, 1% Triton X-563 19 100, 40 U/ml RNasin, EDTA-free complete protease inhibitors (Roche)). Lysates were 564 rotated end over end for 10 min at 4°C and cleared by centrifugation at 10,000 g for 10 565 min at 4°C. 40 µl lysate were saved for Western blot analysis before the cellular lysate 566 was loaded onto linear 17.5-50% sucrose gradients (dissolved in 20 mM Tris-HCl pH 7.5, 567 5 mM MgCl 2 , 150 mM NaCl). Sucrose density gradient centrifugation was carried out at 568 35,000 rpm at 4°C using a SW60 rotor (Beckman) for 2.5 h. Polysome profiles were 569 recorded by measuring the absorbance at 254 nm using a Teledyne ISCO Foxy Jr. or a 570
Teledyne ISCO Foxy R1 system in combination with PeakTrak software. Profiles were 571 then aligned manually according to the 80S peak, and the percentage of polysomal 572 ribosomes was calculated by dividing the area under the curve of the polysomal 573 ribosomes by the total area under the curve. 574
Polysome fractionation 575
During gradient elution, fractions of approximately 300 µl were collected every 14 576 seconds. For RNA isolation, 300 µl Urea buffer (10 mM Tris pH 7.5, 350 mM NaCl, 10 mM 577 EDTA, 1 % SDS and 7 M urea) containing 25 fmol rabbit HBB2 in vitro transcript and 300 578 µl Phenol:Chloroform:Isamylalcohol (PCI) (25:24:1) were added to each fraction. After 579 phase separation, RNA was isolated from the aqueous phase and precipitated using 580 isopropanol. RNA levels in the different fractions were subsequently analyzed by qPCR as 581 follows: RNA was reverse transcribed using the MMLV reverse transcriptase (Promega), 582 followed by cDNA amplification using the PowerUp SYBR Green Master Mix (Thermo 583
Fisher Scientific) and the QuantStudio 5 Real-TimePCR system (Thermo Fisher 584 Scientific). All CT values were normalized to the HBB2 spike-in transcript in order to 585 correct for isolation differences. 586
For protein purification, 300 µl Tris-HCl (20 mM, pH 7.5) and 10 µl StrataClear 587 beads were added to each fraction. Samples were rotated end over end at 4°C overnight, 588 centrifuged at ~ 100 g for 2 min., and proteins were eluted from the beads using SDS 589 sample buffer. 590
Ribosome footprint (Ribo-Seq) analysis 591 RPE1 cells were cultured in the absence of FBS for 48 h. Afterwards, cells were incubated 592 for 4 h in fresh medium without FBS supplemented with either DMSO or Ro3306, washed 593 once in ice-cold PBS supplemented with 100 µg/ml CHX and harvested by scraping in 594 polysome lysis buffer. Lysates were rotated end over end for 10 min at 4°C and cleared 595 by centrifugation at 10,000 g for 10 min at 4°C. The DMSO-and Ro3306-treated samples 596 were adjusted to the same OD260 before yeast polysome lysate (2% of the RPE1 lysates 597 Figure 1 . SG assembly screen under regular growth conditions. (A) The assembly of SGs was monitored in HeLa cells stably expressing GFP-G3BP1 following kd of 711 kinases and 256 phosphatases. Cells were transfected with 4 individual siRNAs per gene and 72 hours later fixed for fluorescence microscopy. Representative images of the screen are shown; arrowheads indicate SG-containing cells. (B) The screen was analyzed by calculating a SG score for each kinase/phosphatase kd, and the result was depicted by sorting all kds according to their SG score. Candidate kinases/phosphatases were identified by a SG score >10 (with at least 2 different siRNAs) or >40 (with 1 siRNA); some of the candidates were labeled in the graph. (C) The graph depicts cellular functions highly represented among the candidate kinases/phosphatases, based on functional annotation in NCBI Gene and Uniprot databases. Figure 5 . CDK1-dependent phosphorylation events associated with ribosomes. (A) HeLa cell lysates, either untreated or subjected to RNase I digestion, were fractionated following sucrose density gradient centrifugation. Association of RPS10 and CDK1 with the different fractions was monitored by Western blot analysis. (B) For phosphoproteomics of ribosomal fractions, HeLa cells were SILAC-labeled and either treated with DMSO or Ro3306 for 4 h. After lysis and disassembly of polysomes in low magnesium buffer, samples were mixed, and ribosomal fractions obtained by sucrose density centrifugation were subjected to phosphopeptide enrichment using PhosSelect iron affinity gel IMAC beads and analyzed by mass spectrometry followed by MaxQuant analysis. For all phosphopeptides detected under both conditions, the ratio (∆ phosphopeptide abundance, 4h/0h Ro3306) was plotted against the ratio of the corresponding total protein (∆ protein abundance, 4h/0h Ro3306). Phosphopeptides derived from LARP1 (blue), RPS6 (red) and other translation regulators (orange) are color-coded.
